June 21, 2024

1871-LB: Phase 1 Topline Safety, Efficacy, and Pharmacokinetics of Oral Ecnoglutide

Key Points

Key points are not available for this paper at this time.

Abstract

Introduction Sciwind Biosciences. G. Wanjun: Employee; Sciwind Biosciences. Q. Zheng: Employee; Sciwind Biosciences. J. Deng: Employee; Sciwind Biosciences. E. Adegbite: Employee; Sciwind Biosciences. S. Ross: None. L. Telusca: None. C.L. Jones: Employee; Sciwind Biosciences. M. Fenaux: None. S. Xu: None. M.K. Junaidi: None. Funding Sciwind Biosciences

Bookmark

Cite This Study

ZHU et al. (Fri,) studied this question.

synapsesocial.com/papers/68e63d15b6db6435875ceec7 https://doi.org/https://doi.org/10.2337/db24-1871-lb

Bookmark